Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
Dig Endosc. 2012 Jul;24(4):220-5. doi: 10.1111/j.1443-1661.2011.01215.x. Epub 2011 Dec 29.
Limited data are available regarding the use of endoscopic submucosal dissection (ESD) for superficial esophageal cancers ≥ 50 mm in diameter. The aim of the present study was to investigate the safety and success of ESD for superficial esophageal cancers ≥ 50 mm.
A total of 39 patients with superficial esophageal squamous cell carcinoma ≥ 50 mm were treated with ESD at Osaka Medical Center for Cancer and Cardiovascular Diseases between January 2004 and April 2011, and were analyzed in a retrospective study.
En bloc resection was achieved in all patients. One mediastinal emphysema without perforation occurred during the procedure. Stricture developed in 11 of 39 patients, requiring a median of five endoscopic balloon dilatation procedures. Thirty-three clinical epithelial or lamina propria mucosal cancers were treated by ESD with curative intent, of which invasion into the muscularis mucosa or deeper was detected in seven and lymphovascular involvement in three. The en bloc resection rate was 100% with a tumor-free margin achieved in 92% of lesions. The curative resection and complication rates during ESD were 70% and 2.5%, respectively.
ESD achieved a high en bloc resection rate of 92% with a tumor-free margin. Curative resection rate of ESD in patients with clinical epithelial or lamina propria mucosal cancers was not low at 70%. However, the risk of stricture must be taken into account when considering the use of ESD in lesions ≥ 50 mm.
对于直径≥50mm 的表浅性食管癌症,内镜黏膜下剥离术(ESD)的应用数据有限。本研究旨在探讨 ESD 治疗直径≥50mm 的表浅性食管癌症的安全性和成功率。
回顾性分析 2004 年 1 月至 2011 年 4 月期间大阪医疗中心癌症与心血管疾病中心采用 ESD 治疗的 39 例直径≥50mm 的表浅性食管鳞状细胞癌患者的资料。
所有患者均达到整块切除。1 例患者在操作过程中发生纵隔气肿但未穿孔。39 例患者中有 11 例发生狭窄,需要中位数为 5 次内镜球囊扩张。33 例临床上皮或固有层黏膜癌症采用 ESD 治疗,有 7 例侵犯黏膜肌层或更深,3 例有血管淋巴管浸润。整块切除率为 100%,92%的病变达到无肿瘤切缘。ESD 的根治性切除率和并发症发生率分别为 70%和 2.5%。
ESD 达到了 92%的高整块切除率和无肿瘤切缘。临床上皮或固有层黏膜癌症患者 ESD 的根治性切除率不低,为 70%。然而,当考虑在直径≥50mm 的病变中使用 ESD 时,必须考虑狭窄的风险。